| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a856578378df787cf545d520b0d7a959 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate |
2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ba8c68cc71c70b3f6e8f0a767bcd42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_202546abc6160e5c0659f0f67638582c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f077d211236ff9a07e206033dc1fb346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a87acfb11525c41305523132649a8cb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401a46c15d28e30b9f250b6b5802274b |
| publicationDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011016832-A |
| titleOfInvention |
Soluble form osmotic dose delivery system |
| abstract |
A therapeutically effective dose of a wide range of drugs at a controlled rate and over a long period of time without the need for a polymer that swells or expands within the tablet wall to physically push the drug particles into their intended use environment. Providing an osmotic delivery system in the form of a tablet that effectively delivers a drug. (A) a semi-permeable wall that remains intact during drug delivery and has at least one flow path therethrough; (b) an infiltration comprising a single homogeneous composition within the wall A delivery system comprising essentially (i) a pharmaceutical active, (ii) at least one non-swelling solubilizer that enhances the solubility of the pharmaceutical active, (iii) at least one An osmotic formulation delivery system comprising: a non-swelled osmotic agent; and (iv) a non-swelled wicking agent dispersed throughout the composition that enhances surface area contact between the formulation and the incoming aqueous fluid. [Selection figure] None |
| priorityDate |
1996-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |